TNF and Bone Remodeling

Overview

Journal Curr Osteoporos Rep

Publisher Current Science

Specialties Endocrinology
Orthopedics

Date 2017 May 7

PMID 28477234

Citations 84

Authors

Baohong Zhao

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: The mechanisms involved in the TNF-mediated deregulated bone remodeling are little appreciated. This review will discuss and summarize the impact of TNF, Notch, and RBP-J signaling on bone remodeling.

Recent Findings: The integrity of the adult skeleton undergoes constant and dynamic remodeling throughout life to maintain a proper bone homeostasis, which is achieved by the essential tight control of coupling between osteoclast-mediated bone resorption and osteoblast-mediated bone formation. The studies in this field include not only the differentiation and function of osteoblasts and osteoclasts, but also the mechanisms that simultaneously control both cell types during bone remodeling. Chronic inflammation is one of the most evident and common pathological settings that often leads to deregulated bone remodeling. The resounding success of TNF blockade therapy has demonstrated a key role for TNF in inflammation and the pathogenesis of inflammatory bone resorption associated with diseases such as rheumatoid arthritis and periodontitis. Recent studies have highlighted the function of Notch and RBP-J signaling in both physiological and TNF-mediated inflammatory bone remodeling.

Citing Articles

Long non-coding RNA fine-tunes bone homeostasis and repair by orchestrating cellular crosstalk and β-catenin-OPG/Jagged1 pathway.

Qin Y, Shirakawa J, Xu C, Chen R, Yang X, Ng C Elife. 2024; 13.

PMID: 39714456 PMC: 11666238. DOI: 10.7554/eLife.98900.

Unraveling the Bone-Brain Axis: A New Frontier in Parkinson's Disease Research.

Liu T, Wu H, Li J, Zhu C, Wei J Int J Mol Sci. 2024; 25(23).

PMID: 39684552 PMC: 11641043. DOI: 10.3390/ijms252312842.

Distinct role of Klotho in long bone and craniofacial bone: skeletal development, repair and regeneration.

Chen X, Wei Y, Li Z, Zhou C, Fan Y PeerJ. 2024; 12:e18269.

PMID: 39465174 PMC: 11505971. DOI: 10.7717/peerj.18269.

Local Application of a New Chalconic Derivative (Chalcone T4) Reduces Inflammation and Oxidative Stress in a Periodontitis Model in Rats.

Camilli A, de Godoi M, Costa V, Fernandes N, Cirelli G, da Silva L Antioxidants (Basel). 2024; 13(10).

PMID: 39456446 PMC: 11504102. DOI: 10.3390/antiox13101192.

Progress and Challenges of Topical Delivery Technologies Meditated Drug Therapy for Osteoarthritis.

Shentu C, Wang H, Peng X, Xu D, Qian L, Chen Y Int J Nanomedicine. 2024; 19:8337-8352.

PMID: 39161359 PMC: 11330747. DOI: 10.2147/IJN.S466437.

References

Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S . Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med. 2000; 191(2):275-86. PMC: 2195746. DOI: 10.1084/jem.191.2.275. View

Azuma Y, Kaji K, Katogi R, Takeshita S, Kudo A . Tumor necrosis factor-alpha induces differentiation of and bone resorption by osteoclasts. J Biol Chem. 2000; 275(7):4858-64. DOI: 10.1074/jbc.275.7.4858. View

Li J, Sarosi I, Yan X, Morony S, Capparelli C, Tan H . RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A. 2000; 97(4):1566-71. PMC: 26475. DOI: 10.1073/pnas.97.4.1566. View

Lam J, Takeshita S, Barker J, Kanagawa O, Ross F, Teitelbaum S . TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest. 2000; 106(12):1481-8. PMC: 387259. DOI: 10.1172/JCI11176. View

Ishii H, Nakazawa M, Yoshino S, Nakamura H, Nishioka K, Nakajima T . Expression of notch homologues in the synovium of rheumatoid arthritis and osteoarthritis patients. Rheumatol Int. 2001; 21(1):10-4. DOI: 10.1007/s002960100119. View

Yamada T, Yamazaki H, Yamane T, Yoshino M, Okuyama H, Tsuneto M . Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. Blood. 2002; 101(6):2227-34. DOI: 10.1182/blood-2002-06-1740. View

Goldring S . Pathogenesis of bone and cartilage destruction in rheumatoid arthritis. Rheumatology (Oxford). 2003; 42 Suppl 2:ii11-6. DOI: 10.1093/rheumatology/keg327. View

Vigouroux S, Yvon E, Wagner H, Biagi E, Dotti G, Sili U . Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes. J Virol. 2003; 77(20):10872-80. PMC: 224961. DOI: 10.1128/jvi.77.20.10872-10880.2003. View

Maekawa Y, Tsukumo S, Chiba S, Hirai H, Hayashi Y, Okada H . Delta1-Notch3 interactions bias the functional differentiation of activated CD4+ T cells. Immunity. 2003; 19(4):549-59. DOI: 10.1016/s1074-7613(03)00270-x. View

10.

Calvi L, Adams G, Weibrecht K, Weber J, Olson D, Knight M . Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003; 425(6960):841-6. DOI: 10.1038/nature02040. View

11.

Ando K, Kanazawa S, Tetsuka T, Ohta S, Jiang X, Tada T . Induction of Notch signaling by tumor necrosis factor in rheumatoid synovial fibroblasts. Oncogene. 2003; 22(49):7796-803. DOI: 10.1038/sj.onc.1206965. View

12.

Li P, Schwarz E, OKeefe R, Ma L, Looney R, Ritchlin C . Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice. Arthritis Rheum. 2004; 50(1):265-76. DOI: 10.1002/art.11419. View

13.

Amsen D, Blander J, Lee G, Tanigaki K, Honjo T, Flavell R . Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell. 2004; 117(4):515-26. DOI: 10.1016/s0092-8674(04)00451-9. View

14.

Hayward S . Viral interactions with the Notch pathway. Semin Cancer Biol. 2004; 14(5):387-96. DOI: 10.1016/j.semcancer.2004.04.018. View

15.

Maillard I, Fang T, Pear W . Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev Immunol. 2005; 23:945-74. DOI: 10.1146/annurev.immunol.23.021704.115747. View

16.

Kim N, Kadono Y, Takami M, Lee J, Lee S, Okada F . Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J Exp Med. 2005; 202(5):589-95. PMC: 2212875. DOI: 10.1084/jem.20050978. View

17.

Yabe Y, Matsumoto T, Tsurumoto T, Shindo H . Immunohistological localization of Notch receptors and their ligands Delta and Jagged in synovial tissues of rheumatoid arthritis. J Orthop Sci. 2005; 10(6):589-94. DOI: 10.1007/s00776-005-0943-3. View

18.

Beres T, Masui T, Swift G, Shi L, Henke R, MacDonald R . PTF1 is an organ-specific and Notch-independent basic helix-loop-helix complex containing the mammalian Suppressor of Hairless (RBP-J) or its paralogue, RBP-L. Mol Cell Biol. 2005; 26(1):117-30. PMC: 1317634. DOI: 10.1128/MCB.26.1.117-130.2006. View

19.

Teitelbaum S . Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res Ther. 2005; 8(1):201. PMC: 1526550. DOI: 10.1186/ar1857. View

20.

Yao Z, Li P, Zhang Q, Schwarz E, Keng P, Arbini A . Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-Fms expression. J Biol Chem. 2006; 281(17):11846-55. DOI: 10.1074/jbc.M512624200. View